|Articles|April 27, 2018

Drug Cost Implications Highlight SPT Week in Review

Top news of the week from Specialty Pharmacy Times.

Switch to Extended Half-Life Hemophilia Factor Products Found to Double Costs

Pharmacy benefit manager study indicates that moving patients with hemophilia from standard half-life to extended half-life coagulation factor products carries a significant cost increase.

Click to read more...

Drug Costs Responsible for Nearly Entire Price Tag of Hereditary Angioedema Care

Pharmacy benefit manager reports specialty drugs drive 97% of spending for hereditary angioedema care.

Click to read more...

Specialty Drug Spending Grows While Traditional Medicine Spending Drops

Spending on specialty medications is rapidly approaching half of overall medicine spending from a small volume of prescriptions filled.

Click to read more...

Specialty Drugs Power Growth in Pharmacy Benefit Spend

New treatments for cystic fibrosis, migraines, and multiple sclerosis expected to help push specialty drug costs on the pharmacy benefit to nearly 50% of total drug spending by 2020.

Click to read more...

Adherence Lacking to High-Cost Multiple Sclerosis Disease-Modifying Drugs

Study finds improving adherence to disease-modifying multiple sclerosis medications could reduce clinical relapses while saving on medical costs.

Click to read more...

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Latest CME

Online Article

Advancing Stroke Prevention: The Pharmacist’s Role in Implementing the 2024 Guidelines

1.0 Credit / Cardiology

On-Demand Virtual Symposium

Balancing Pain Management and Opioid Use Disorder: Recognition, Treatment, and Compassionate Communication in Pharmacy Practice

1.0 Credit / Pain Management

Online Article

The Impact of Pharmacists and Pharmacy Technicians in Recognizing and Responding to Human Trafficking (Pharmacist Credit)

2.0 Credits / Human Trafficking, Law

Online Article

Securing the Supply Chain: The Pharmacists’ Role in DSCSA Compliance

1.0 Credit / Law

Drug Cost Implications Highlight SPT Week in Review

Related Content

New Research Suggests Bempedoic Acid Outperforms Ezetimibe for Heart Health in Patients with Type 2 Diabetes

ADA 2026: Pharmacist Integration Into Refill Workflows Reduces Provider Burnout and Catches Safety Risks

Beyond Weight Loss: Exploring the Renal and Anti-Inflammatory Benefits of High-Dose Semaglutide

ADA 2026: The 2026 ADA Standards – A Pharmacist's Guide to Cardiorenal Risk Reduction

Oncology PulsePoints: Metastatic CRPC ASCO Living Guidelines Updates

Latest CME

Advancing Stroke Prevention: The Pharmacist’s Role in Implementing the 2024 Guidelines

Balancing Pain Management and Opioid Use Disorder: Recognition, Treatment, and Compassionate Communication in Pharmacy Practice

The Impact of Pharmacists and Pharmacy Technicians in Recognizing and Responding to Human Trafficking (Pharmacist Credit)

Securing the Supply Chain: The Pharmacists’ Role in DSCSA Compliance

Bridging Knowledge Gaps in HR+/HER2– Early-Stage Breast Cancer

Understanding Type 2 Inflammation and Its Role Across Various Immune-Related Diseases

Precision Matters: Foundations of Biomarker-Driven Care in Non-Small Cell Lung Cancer

Cardiorenal Protection With SGLT2 Inhibitors: Perspectives for Managed Care

Bridging Innovation and Access in HR-Positive/HER2-Negative Metastatic Breast Cancer: Implications for Managed Care

Navigating Advanced Prostate Cancer Treatment: Optimizing Novel Therapeutic Strategies for Managed Care Pharmacists

From Payload to Patient: Managing Toxicities of Antibody-Drug Conjugates Directed at HER2 and TROP2

Managing Steroid-Refractory Chronic Graft-versus-Host Disease With Novel Therapies: Opportunities for Pharmacist-Led Interventions

Beyond the Prescription: Tackling Social Isolation for Better Health (Pharmacy Technician Credit)

Understanding and Personalizing Chronic Obstructive Pulmonary Disease Diagnosis and Treatment

Directions in Pharmacy 2026

From Evidence to Access: Integrating SGLT2 Inhibitors Across the Cardiorenal-Metabolic Continuum

Identifying and Personalizing Iron Deficiency Anemia Treatment in Patients With Cancer

Iron Deficiency Anemia Treatment Considerations in Women’s Health

Neuropsychiatry Day of Education 2026

Protecting Against Meningococcal Disease: Updates on Vaccines, Guidelines, and Pharmacist Best Practices

Immunology Specialty Pharmacy Day of Education 2026

Oncology Pharmacists Connect 2026

Improving Outcomes in Lipid Management: Aligning Managed Care Policy With Emerging Guideline Updates and Non-Statin Therapeutic Advances

Managing Iron Replacement Therapies for Patients With Inflammatory Bowel Disease

The Impact of Pharmacists and Pharmacy Technicians in Recognizing and Responding to Human Trafficking (Pharmacy Technician Credit)

Breast Cancer Day of Education 2026

Neuropsychiatry Day of Education 2026

Optimizing HER2-Directed Therapy in Metastatic Breast Cancer: From HER2-Positive to HER2-Ultralow

From Flares to Freedom: Navigating the Journey of Patients With Chronic Spontaneous Urticaria With Next-Generation Therapies

Innovations in Lymphoma Treatment and the Growing Impact of Bispecific Antibodies

Addressing the Burden of Hemolysis in Paroxysmal Nocturnal Hemoglobinuria: The Pharmacist's Contribution to Patient Care

Navigating Novel Therapies in Steroid-Refractory cGVHD: Practical Strategies for Community-Based Oncology Pharmacists

Understanding mRNA Vaccines: Dispelling Myths and Empowering Pharmacists to Counsel Patients

Navigating the Legal Landscape of Telehealth: Updates and Implications for Pharmacists and Technicians

Reducing the Treatment Burden in HIV Management: The Pharmacist’s Role in Long-Acting Injectable Adoption

Innovations in Retinal Therapies: A Managed Care Perspective on Anti-VEGF Advancements

Beyond the Nasal Passage: Managing Chronic Rhinosinusitis With Nasal Polyps With Biologics and Pharmacist-Led Approaches

Transforming Gout Care: Navigating Barriers and Therapeutic Advances in Disease Management

Pharmacists at the Forefront: Enhancing Targeted Therapy Implementation and Patient Outcomes in Advanced Gastric Cancer

Managing Overactive Bladder in Older Adults: Challenges and Strategies for Long-Term Care

HER2-Positive Metastatic Breast Cancer: A Managed Care Perspective on Emerging Therapies and Clinical Data

Exploring Immunotherapy Strategies in Endometrial Cancer

Biomarker Testing in Practice: Navigating Modalities and Multidisciplinary Decision-Making

Best Practice Approaches for Understanding Chronic Obstructive Pulmonary Disease and Precision Medicine Treatment

Evolving Care: Treating Demodex Blepharitis for Pharmacists

Immunology Specialty Pharmacy Day of Education 2026

Stimulant Stewardship: A Pharmacist’s Guide to ADHD Prescribing During Drug Shortages

Not All Bispecifics Are Equal: Mechanism-Based Approaches to Selection and Management in Oncology Practice

Targeting Genomic Drivers to Optimize ROS1-Directed Therapy in NSCLC

From Molecule to Medication: Integrating Menin Inhibitors in AML Practice

The Educated Pharmacist: Using Patient Insights to Personalize Insulin Therapy and Prevent Clinical Inertia

Enhancing Patient Outcomes in Metastatic Colorectal Cancer: Equipping Community, Veterans Affairs, and Oncology Pharmacists to Navigate Care in the Third-Line Setting and Beyond

Breast Cancer Day of Education 2026

Outsmart the Algorithm: Combatting Misinformation at the Pharmacy Counter

Translating KDIGO Updates and Clinical Evidence Into Managed Care Decision-Making in IgA Nephropathy

The Pharmacist's Role in Palliative and End of Life Symptom Management (Pharmacy Technician Credit)

Clinical Presentation of Hyperglycemia with PI3K and AKT Inhibitors

Optimizing Lipid Management in Statin-Intolerant Populations: Payer Strategies for Evidence-Based Access and Risk Reduction

Targeting the Root of Autoimmunity in Generalized Myasthenia Gravis: Pharmacist Strategies for Integrating FcRn Therapies Into Specialty Practice

IL-23 Inhibitors in Psoriasis: Optimizing Access and Patient Outcomes Across Integrated Systems

Utilizing VMAT-2 Inhibitors for the Management of Tardive Dyskinesia: The Role of Long-Term Care Pharmacists

Influenza Immunization in Older Adults: Enhanced Vaccines and Best Practices for Long-Term Care Pharmacists

Multidisciplinary Insights and Strategies for Patients Treated With PI3K and AKT Inhibitors to Prevent Hyperglycemia

New Horizons in ATTR-CM: Therapeutic Advances and Strategic Insights

Advancing Treatment Strategies in Extensive-Stage Small Cell Lung Cancer: Enhancing Pharmacist Competence in Therapy Selection, Administration, and Adverse Event Management

Bridging Clinical and Access Gaps in Phenylketonuria: A Managed Care Perspective

Advancing the Idiopathic Pulmonary Fibrosis Treatment Landscape: What’s Next in Care

Enhancing The Role of Oncology Pharmacists in Multidisciplinary Myeloproliferative Neoplasm Care

Collaborative Practice Agreement Implementation and Adherence: A Practical Roadmap for Oncology Pharmacists

Sugar, We’re Going Down: Navigating Glycemic Control in the Era of PI3K/AKT Inhibition for Breast Cancer

Redefining Metabolic Dysfunction-Associated Steatohepatitis Treatment: Managed Care Insights on New Therapies Targeting Metabolic Dysfunction

Addressing Gaps in Care for the Rapid and Long-Term Management of Hyperkalemia With Novel Oral Potassium Binding Agents: Insights for Managed Care Professionals